Statistically controlled identification of differentially expressed genes in one-to-one cell line comparisons of the CMAP database for drug repositioning
暂无分享,去创建一个
Zheng Guo | Kai Song | Jun He | Qingzhou Guan | Haidan Yan | H. Cai | Xiangyu Li | Rou Chen | Xianlong Wang | Weicheng Zheng | Hua-Ping Liu
[1] Nikolas Dovrolis,et al. Laying in silico pipelines for drug repositioning: a paradigm in ensemble analysis for neurodegenerative diseases. , 2017, Drug discovery today.
[2] G. Pond,et al. Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials , 2017, Oncotarget.
[3] Zheng Guo,et al. Differential expression analysis for individual cancer samples based on robust within-sample relative gene expression orderings across multiple profiling platforms , 2016, Oncotarget.
[4] Kathleen M Jagodnik,et al. Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd , 2016, Nature Communications.
[5] Soo-Youl Kim,et al. Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion , 2016, Oncotarget.
[6] Giovanni Coppola,et al. A Systems-Level Analysis of the Peripheral Nerve Intrinsic Axonal Growth Program , 2016, Neuron.
[7] D. Ettinger,et al. NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 4.2016. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.
[8] Libin Chen,et al. Critical limitations of prognostic signatures based on risk scores summarized from gene expression levels: a case study for resected stage I non-small-cell lung cancer , 2016, Briefings Bioinform..
[9] Wolfgang Huber,et al. A chemical–genetic interaction map of small molecules using high‐throughput imaging in cancer cells , 2015, Molecular systems biology.
[10] Sheng Wei,et al. Targeting oncogenic KRAS in non-small cell lung cancer cells by phenformin inhibits growth and angiogenesis. , 2015, American journal of cancer research.
[11] Livia Perfetto,et al. SIGNOR: a database of causal relationships between biological entities , 2015, Nucleic Acids Res..
[12] Diego di Bernardo,et al. Drug-set enrichment analysis: a novel tool to investigate drug mode of action , 2015, Bioinform..
[13] Zheng Guo,et al. Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments , 2015, Scientific Reports.
[14] Jia Wang,et al. Synergistic Effect of Phenformin in Non-Small Cell Lung Cancer (NSCLC) Ionizing Radiation Treatment , 2015, Cell Biochemistry and Biophysics.
[15] Pankaj Agarwal,et al. Systematic evaluation of connectivity map for disease indications , 2014, Genome Medicine.
[16] Robert Petryszak,et al. ArrayExpress update—simplifying data submissions , 2014, Nucleic Acids Res..
[17] Jean-Pierre A. Kocher,et al. A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis , 2013, Bioinform..
[18] Robert Tibshirani,et al. Finding consistent patterns: A nonparametric approach for identifying differential expression in RNA-Seq data , 2013, Statistical methods in medical research.
[19] Erika Martinelli,et al. Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines , 2013, Clinical Cancer Research.
[20] F. Iorio,et al. Transcriptional data: a new gateway to drug repositioning? , 2013, Drug discovery today.
[21] Liu Wei,et al. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. , 2013, Cancer cell.
[22] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[23] Haiyang Xie,et al. Reversing Effect of Ring Finger Protein 43 Inhibition on Malignant Phenotypes of human Hepatocellular Carcinoma , 2012, Molecular Cancer Therapeutics.
[24] Jing Zhu,et al. GO-function: deriving biologically relevant functions from statistically significant functions , 2012, Briefings Bioinform..
[25] Alexander A. Morgan,et al. Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease , 2011, Science Translational Medicine.
[26] Y. Luqmani,et al. Estrogen Receptor Silencing Induces Epithelial to Mesenchymal Transition in Human Breast Cancer Cells , 2011, PloS one.
[27] David M. Simcha,et al. Tackling the widespread and critical impact of batch effects in high-throughput data , 2010, Nature Reviews Genetics.
[28] S. Wacholder,et al. Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.
[29] J. Weinstein,et al. Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses. , 2007, Cancer research.
[30] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[31] Richard J. Fox,et al. A two-sample Bayesian t-test for microarray data , 2006, BMC Bioinformatics.
[32] Il-Jin Kim,et al. Identification of Genes with Differential Expression in Acquired Drug-Resistant Gastric Cancer Cells Using High-Density Oligonucleotide Microarrays , 2004, Clinical Cancer Research.
[33] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[34] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[35] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[36] A K Bahn,et al. Application of binomial distribution to medicine: comparison of one sample proportion to an expected proportion (for small samples). Evaluation of a new treatment. Evaluation of a risk factor. , 1969, Journal of the American Medical Women's Association.
[37] Qiang Sun,et al. Individual-level analysis of differential expression of genes and pathways for personalized medicine , 2015, Bioinform..
[38] Justin Lamb,et al. The Connectivity Map: a new tool for biomedical research , 2007, Nature Reviews Cancer.
[39] Alex E. Lash,et al. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..
[40] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[41] Chi-Ying F. Huang,et al. Selection of DDX 5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap resampling scheme , 2007 .